France
· Delayed Price · Currency is EUR Aelis Farma Statistics
Total Valuation
Aelis Farma has a market cap or net worth of EUR 36.22 million. The enterprise value is 28.72 million.
| Market Cap | 36.22M |
| Enterprise Value | 28.72M |
Important Dates
The next estimated earnings date is Tuesday, December 17, 2024.
| Earnings Date | Dec 17, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Aelis Farma has 13.62 million shares outstanding. The number of shares has increased by 4.83% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 13.62M |
| Shares Change (YoY) | +4.83% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 38.27% |
| Owned by Institutions (%) | 0.43% |
| Float | 3.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.26 |
| PB Ratio | 3.52 |
| P/TBV Ratio | 3.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.09 |
| EV / Sales | 2.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.17 |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.51.
| Current Ratio | 2.97 |
| Quick Ratio | 2.69 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.38 |
| Interest Coverage | -40.88 |
Financial Efficiency
Return on equity (ROE) is -51.97% and return on invested capital (ROIC) is -26.37%.
| Return on Equity (ROE) | -51.97% |
| Return on Assets (ROA) | -17.67% |
| Return on Capital (ROIC) | -26.37% |
| Revenue Per Employee | 414,654 |
| Profits Per Employee | -270,308 |
| Employee Count | 26 |
| Asset Turnover | 0.40 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.85% in the last 52 weeks. The beta is 0.09, so Aelis Farma's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -79.85% |
| 50-Day Moving Average | 3.49 |
| 200-Day Moving Average | 9.81 |
| Relative Strength Index (RSI) | 23.02 |
| Average Volume (20 Days) | 1,975 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aelis Farma had revenue of EUR 10.78 million and -7.03 million in losses. Loss per share was -0.53.
| Revenue | 10.78M |
| Gross Profit | 10.78M |
| Operating Income | -7.69M |
| Pretax Income | -7.03M |
| Net Income | -7.03M |
| EBITDA | -7.55M |
| EBIT | -7.69M |
| Loss Per Share | -0.53 |
Balance Sheet
The company has 12.59 million in cash and 5.08 million in debt, giving a net cash position of 7.50 million or 0.55 per share.
| Cash & Cash Equivalents | 12.59M |
| Total Debt | 5.08M |
| Net Cash | 7.50M |
| Net Cash Per Share | 0.55 |
| Equity (Book Value) | 9.94M |
| Book Value Per Share | 0.76 |
| Working Capital | 12.44M |
Cash Flow
In the last 12 months, operating cash flow was -13.10 million and capital expenditures -171,000, giving a free cash flow of -13.27 million.
| Operating Cash Flow | -13.10M |
| Capital Expenditures | -171,000 |
| Free Cash Flow | -13.27M |
| FCF Per Share | -0.97 |
Margins
Gross margin is 100.00%, with operating and profit margins of -71.29% and -65.19%.
| Gross Margin | 100.00% |
| Operating Margin | -71.29% |
| Pretax Margin | -65.20% |
| Profit Margin | -65.19% |
| EBITDA Margin | -70.07% |
| EBIT Margin | -71.29% |
| FCF Margin | -123.05% |
Dividends & Yields
Aelis Farma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.83% |
| Shareholder Yield | -4.83% |
| Earnings Yield | -20.00% |
| FCF Yield | -36.62% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Aelis Farma has an Altman Z-Score of 9.68.
| Altman Z-Score | 9.68 |
| Piotroski F-Score | n/a |